Follow
Paola M. Perez Rivera
Paola M. Perez Rivera
Verified email at ucsf.edu
Title
Cited by
Cited by
Year
Prostate-specific membrane antigen ligand positron emission tomography in men with nonmetastatic castration-resistant prostate cancer
WP Fendler, M Weber, A Iravani, MS Hofman, J Calais, J Czernin, H Ilhan, ...
Clinical Cancer Research 25 (24), 7448-7454, 2019
2252019
Effect of ELP sequence and fusion protein design on concentrated solution self-assembly
G Qin, PM Perez, CE Mills, BD Olsen
Biomacromolecules 17 (3), 928-934, 2016
262016
Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary Metastases.
PM Perez, TA Hope, SC Behr, EJ Small, RR Flavell
Clinical nuclear medicine 44 (1), e28-e32, 2019
232019
PiFlow: A biocompatible low-cost programmable dynamic flow pumping system utilizing a Raspberry Pi Zero and commercial piezoelectric pumps
T Kassis, PM Perez, CJW Yang, LR Soenksen, DL Trumper, LG Griffith
HardwareX 4, e00034, 2018
21*2018
Factors predicting metastatic disease in 68Ga-PSMA-11 PET positive osseous lesions in prostate cancer
LW Chiu, C Lawhn-Heath, S Behr, R Juarez, PM Perez, I Lobach, ...
Journal of Nuclear Medicine, jnumed. 119.241174, 2020
192020
Heterogeneous Uptake of 18F-FDG and 68Ga-PSMA-11 in Hepatocellular Carcinoma.
PM Perez, RR Flavell, RK Kelley, S Umetsu, SC Behr
Clinical nuclear medicine 44 (3), e133-e135, 2019
132019
Amino Acid‐Derived Sensors for Specific Zn2+ Detection Using Hyperpolarized 13C Magnetic Resonance Spectroscopy
S Wang, DE Korenchan, PM Perez, C Taglang, TR Hayes, R Sriram, ...
Chemistry–A European Journal 25 (51), 11842-11846, 2019
82019
PSMA-PET results in a nonmetastatic castration-resistant prostate cancer spartan-like population that is negative by conventional imaging
M Hofman, W Fendler, M Weber, A Iravani, J Calais, J Czernin, H Ilhan, ...
BJU INTERNATIONAL 123, 46-46, 2019
52019
Prostate-specific membrane antigen positron-emission tomography (PSMA-PET) in high-risk nonmetastatic castration-resistant prostate cancer (nmCRPC) SPARTAN-like patients (pts …
BA Hadaschik, M Weber, A Iravani, MS Hofman, J Calais, J Czernin, ...
European Urology Supplements 18 (1), e698-e699, 2019
42019
Implementation of a Modified Pediatric Asthma Severity Score (MPASS) to Reduce Length of Stay for Pediatric Asthma Patients: A Quality Improvement Study
PM Perez Rivera, J Park, T Clark, M Chan
Journal of Allergy and Clinical Immunology 143 (2), AB211, 2019
22019
Prostate-specific membrane antigen ligand positron emission tomography (PSMA-PET) disease extent and overall survival (OS) in patients (pts) with high-risk nonmetastatic …
BA Hadaschik, M Eiber, M Weber, A Ravi Kumar, J Calais, J Czernin, ...
Journal of Clinical Oncology 41 (16_suppl), 5010-5010, 2023
12023
MON-353 Tumor-Induced Osteomalacia from a Hypervascular Thoracic Paraspinal Mass: Challenges in Diagnosis and Management
PM Perez, P Fu, A Folick, GM Ku, DM Shoback, JYM Lee
Journal of the Endocrine Society 4 (Supplement_1), MON-353, 2020
2020
Prostate-Specific Membrane Antigen Positron-Emission Tomography (PSMA-PET) in High-Risk Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC) SPARTAN-like Patients …
W Fendler, M Weber, A Iravani, MS Hofman, J Calais, J Czernin, H Ilhan, ...
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 46 (SUPPL 1), S47-S47, 2019
2019
PD17-09 PROSTATE-SPECIFIC MEMBRANE ANTIGEN POSITRON EMISSION TOMOGRAPHY (PSMA-PET) IN HIGH-RISK NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) SPARTAN-LIKE …
B Hadaschik*, M Weber, A Iravani, MS Hofman, J Calais, J Czernin, ...
The Journal of Urology 201 (Supplement 4), e309-e309, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–14